January 24, 2013

How much is my drug candidate worth to a partner? A “no-formulas” tour of valuation

Biotech companies seek partnerships (collaborations, licensing deals, JVs, etc) to advance their drug candidates and raise funds. They frequently ask “How much is this drug candidate worth to a partner?” In this ShareVault webinar, Linda Pullan of Pullan Consulting provides a short tour of how both sides of a deal think about valuation.

Linda reviews the different techniques, highlight the key variables, and talk about what makes a drug candidate more valuable to a partner. She covers approximations and shortcuts that can be used when the characteristics of the drug candidate or market aren’t known. Finally, Linda talks about how valuation gets translated to deal terms. Walk away with a clear, conceptual framework for your drug’s valuation.

request the recording
of the webinar

 


 

ABOUT SHAREVAULT

ShareVault’s secure document sharing solution gives pharmaceutical and biotechnology  organizations the confidence to simply and securely share sensitive documents with third parties during due diligence, product development, technology transfers, fundraising, partnering, collaborative research and other activities that require the highest level of document security.

Compared to consumer-grade solutions, ShareVault virtual data rooms offer many features that give you control and document intelligence with the highest level of document-protection and monitoring available. Learn more.